"Atenolol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
Descriptor ID |
D001262
|
MeSH Number(s) |
D02.033.100.624.698.070 D02.033.755.624.698.070 D02.092.063.624.698.070
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Atenolol".
Below are MeSH descriptors whose meaning is more specific than "Atenolol".
This graph shows the total number of publications written about "Atenolol" by people in this website by year, and whether "Atenolol" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2005 | 0 | 1 | 1 |
2007 | 1 | 0 | 1 |
2011 | 0 | 1 | 1 |
2017 | 0 | 1 | 1 |
2018 | 0 | 1 | 1 |
2020 | 0 | 1 | 1 |
2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Atenolol" by people in Profiles.
-
Racial and ethnic differences in response to treatment for Marfan syndrome. Cardiol Young. 2021 Dec; 31(12):1991-1998.
-
ß-Blocker Use and Risk of Mortality in Heart Failure Patients Initiating Maintenance Dialysis. Am J Kidney Dis. 2021 05; 77(5):704-712.
-
Beta-blocker subtypes and risk of low birth weight in newborns. J Clin Hypertens (Greenwich). 2018 11; 20(11):1603-1609.
-
ß-Blocker Exposure in Pregnancy and Risk of Fetal Cardiac Anomalies. JAMA Intern Med. 2017 06 01; 177(6):885-887.
-
Norepinephrine antagonists and cancer risk. Int J Cancer. 2011 Feb 01; 128(3):737-8; author reply 739.
-
Comparative effectiveness of beta-adrenergic antagonists (atenolol, metoprolol tartrate, carvedilol) on the risk of rehospitalization in adults with heart failure. Am J Cardiol. 2007 Aug 15; 100(4):690-6.
-
Medication adherence before an increase in antihypertensive therapy: a cohort study using pharmacy claims data. Clin Ther. 2005 Jun; 27(6):773-81.